Komipharm International

코미팜 · 041960

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$381.7M (₩526.8B)

Overview

Komipharm International is a South Korean pharmaceutical company that develops and supplies medicinal products.

Its customers are broadly within the health-care supply chain, including distributors, clinics, and other medical institutions. The company is listed on KOSDAQ, South Korea's technology and small-cap stock exchange.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$38M

▼ −10.7% YoY

Operating profit · FY2025

US$1.4M

▼ −68.3% YoY

Net income · FY2025

−US$5.8M

Turned to loss

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$30.9M(₩42.6B)	US$42.6M(₩58.8B)	US$38M(₩52.5B)
Operating profit	−US$4.5M(−₩6.3B)	US$4.5M(₩6.2B)	US$1.4M(₩2B)
Net income	−US$4.3M(−₩5.9B)	US$10.6M(₩14.7B)	−US$5.8M(−₩8B)

Revenue

FY2023US$30.9M
FY2024US$42.6M
FY2025US$38M

Operating profit

FY2023−US$4.5M
FY2024US$4.5M
FY2025US$1.4M

Net income

FY2023−US$4.3M
FY2024US$10.6M
FY2025−US$5.8M

Key ratios (FY2025)

ROE

-11.1%

Debt/Eq

85.8%

Op. margin

3.7%

Net margin

-15.3%

Rev. YoY

▼ −10.7%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?